当前位置:首页 - 行情中心 - 大禹生物(920970) - 财务分析 - 现金流量表

大禹生物

(920970)

  

流通市值:3.92亿  总市值:6.20亿
流通股本:7007.13万   总股本:1.11亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金151,925,870.8181,047,924.0134,805,204.18180,988,932.16
  收到的税费返还1,485.481,485.481,485.48-
  收到其他与经营活动有关的现金2,721,438.631,513,890.56538,243.217,219,315.67
  经营活动现金流入小计154,648,794.9282,563,300.0535,344,932.86198,208,247.83
  购买商品、接受劳务支付的现金135,663,662.7781,845,838.8942,965,024.74141,589,702.02
  支付给职工以及为职工支付的现金23,497,102.716,081,523.468,702,606.9229,977,596.24
  支付的各项税费4,237,989.633,282,410.14537,197.287,338,437.66
  支付其他与经营活动有关的现金7,130,650.054,170,819.661,758,209.99,121,147.57
  经营活动现金流出小计170,529,405.15105,380,592.1553,963,038.84188,026,883.49
  经营活动产生的现金流量净额-15,880,610.23-22,817,292.1-18,618,105.9810,181,364.34
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额145,000---
  投资活动现金流入的平衡项目0---
  投资活动现金流入小计145,000---
  购建固定资产、无形资产和其他长期资产支付的现金31,015,579.5629,766,931.4617,328,927.7143,027,308.03
  投资支付的现金1,500,000383,747.74-8,216.72
  投资活动现金流出小计32,515,579.5630,150,679.217,328,927.7143,035,524.75
  投资活动产生的现金流量净额-32,370,579.56-30,150,679.2-17,328,927.71-43,035,524.75
三、筹资活动产生的现金流量:
  取得借款收到的现金156,400,000156,400,00050,400,000107,900,000
  收到其他与筹资活动有关的现金15,000,00015,000,000--
  筹资活动现金流入小计171,400,000171,400,00050,400,000107,900,000
  偿还债务支付的现金136,450,000127,875,00014,475,00066,475,000
  分配股利、利润或偿付利息支付的现金3,403,606.062,227,180.871,028,918.413,048,488.47
  支付其他与筹资活动有关的现金4,035,806.21,842,582.88211,242797,890.8
  筹资活动现金流出小计143,889,412.26131,944,763.7515,715,160.4170,321,379.27
  筹资活动产生的现金流量净额27,510,587.7439,455,236.2534,684,839.5937,578,620.73
四、汇率变动对现金及现金等价物的影响-34,814.99-19,261.26-5,570.36-4,869.48
五、现金及现金等价物净增加额-20,775,417.04-13,531,996.31-1,267,764.464,719,590.84
  加:期初现金及现金等价物余额30,394,424.5830,394,424.5830,394,424.5825,674,833.74
  期末现金及现金等价物余额9,619,007.5416,862,428.2729,126,660.1230,394,424.58
补充资料:
  净利润--26,549,609.3--29,853,181.08
  资产减值准备-15,832,943.01-2,540,919.07
  固定资产和投资性房地产折旧-14,126,275.68-27,767,014.25
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-14,126,275.68-27,767,014.25
  无形资产摊销-621,619.5-1,198,991.2
  处置固定资产、无形资产和其他长期资产的损失--31,078.81--
  公允价值变动损失---2,360
  财务费用-2,504,352.83-3,442,927.7
  投资损失-253.34--22,743.28
  递延所得税---0
  存货的减少--41,440,059.91--19,051,843.88
  经营性应收项目的减少--12,085,161.45-1,093,702.66
  经营性应付项目的增加-23,050,518.83-21,995,463.06
  其他--84,420.92--78,487.93
  现金的期末余额-16,862,428.27-30,394,424.58
  减:现金的期初余额-30,394,424.58-25,674,833.74
  现金及现金等价物的净增加额--13,531,996.31-4,719,590.84
公告日期2026-10-262026-08-242026-04-272026-04-27
审计意见(境内)标准无保留意见
TOP↑